0000899243-18-017972.txt : 20180625
0000899243-18-017972.hdr.sgml : 20180625
20180625182015
ACCESSION NUMBER: 0000899243-18-017972
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180621
FILED AS OF DATE: 20180625
DATE AS OF CHANGE: 20180625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Jeffrey Allen
CENTRAL INDEX KEY: 0001500210
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 18917925
MAIL ADDRESS:
STREET 1: KING PHARMACEUTICALS, INC.
STREET 2: 501 FIFTH STREET
CITY: BRISTOL
STATE: TN
ZIP: 37620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 281 ALBANY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 281 ALBANY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-21
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001500210
Bailey Jeffrey Allen
C/O AILERON THERAPEUTICS, INC.
281 ALBANY STREET
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
6.02
2018-06-21
4
A
0
10000
0.00
A
2028-06-20
Common Stock
10000
10000
D
This option was granted on June 21, 2018. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 21, 2019 or (ii) the date of the Issuer's 2019 Annual Meeting of Stockholders.
/s/ Donald Dougherty, attorney-in-fact for Jeffrey Allen Bailey
2018-06-25